Xenon Pharmaceuticals Inc. - Common Shares (XENE) SEC filings
XENE SEC filings moved a median of -0.95% by the close. XENE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the XENE overview →
59 measured XENE SEC filing events.
Where these XENE SEC filings landedvs 57 measured XENE SEC filing reactions
| Middle 50% of XENE SEC filing reactions | -2.58% to +0.55% |
|---|---|
| Median reaction (to close) | -0.95% |
| Measured reactions | 57 |
Point-in-time · zero look-ahead
Half of the 57 XENE SEC filing events with a measured close landed between -2.58% and +0.55%; 35% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Xenon Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +1.00% | +0.57% | |
| Form 8-K Xenon Pharmaceuticals For: Aug 06 | SEC filing · Form 8-K | +1.00% | +0.57% | |
| Form 8-K Xenon Pharmaceuticals For: Jun 02 | SEC filing · Form 8-K | +1.12% | -0.95% | |
| Form S-8 Xenon Pharmaceuticals | SEC filing · Form S-8 | +1.12% | -0.95% | |
| Form S-8 POS Xenon Pharmaceuticals | SEC filing · Form S-8 | +1.12% | -0.95% | |
| Form 10-Q Xenon Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +0.63% | +0.55% | |
| Form 8-K Xenon Pharmaceuticals For: May 07 | SEC filing · Form 8-K | +0.63% | +0.55% | |
| Form ARS Xenon Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | +1.17% | -2.19% | |
| Form DEF 14A Xenon Pharmaceuticals For: Apr 22 | SEC filing · Form DEF | +1.17% | -2.19% | |
| Form DEFA14A Xenon Pharmaceuticals | SEC filing · Form DEFA14A | +1.17% | -2.19% | |
| Form 8-K Xenon Pharmaceuticals For: Apr 07 | SEC filing · Form 8-K | +0.80% | +1.82% | |
| Form S-8 Xenon Pharmaceuticals | SEC filing · Form S-8 | +0.80% | +1.82% | |
| Form 8-K Xenon Pharmaceuticals For: Mar 13 | SEC filing · Form 8-K | +2.34% | -0.62% | |
| Form 8-K Xenon Pharmaceuticals For: Mar 10 | SEC filing · Form 8-K | +0.83% | -4.92% | |
| Form 8-K Xenon Pharmaceuticals For: Mar 09 | SEC filing · Form 8-K | +2.18% | +3.86% | |
| Form 8-K Xenon Pharmaceuticals For: Feb 27 | SEC filing · Form 8-K | +1.70% | -0.05% | |
| Form 10-K Xenon Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +1.29% | -3.59% | |
| Form 8-K Xenon Pharmaceuticals For: Feb 26 | SEC filing · Form 8-K | +1.29% | -3.59% | |
| Form 8-K Xenon Pharmaceuticals For: Nov 24 | SEC filing · Form 8-K | -0.10% | -1.45% | |
| Form S-8 Xenon Pharmaceuticals | SEC filing · Form S-8 | -0.10% | -1.45% | |
| Form 10-Q Xenon Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -1.42% | -1.64% | |
| Form 8-K Xenon Pharmaceuticals For: Nov 03 | SEC filing · Form 8-K | -1.42% | -1.64% | |
| Form 8-K/A Xenon Pharmaceuticals For: Oct 15 | SEC filing · Form 8-K | +0.31% | +3.28% | |
| Form 8-K Xenon Pharmaceuticals For: Oct 15 | SEC filing · Form 8-K | +1.03% | -0.17% | |
| Form 10-Q Xenon Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +1.06% | — | |
| Form 8-K Xenon Pharmaceuticals For: Aug 11 | SEC filing · Form 8-K | +1.06% | — | |
| Form 8-K Xenon Pharmaceuticals For: Jun 30 | SEC filing · Form 8-K | -1.76% | -2.63% | |
| Form 8-K Xenon Pharmaceuticals For: Jun 04 | SEC filing · Form 8-K | -0.57% | +2.36% | |
| Form 10-Q Xenon Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -6.75% | -9.78% | |
| Form 8-K Xenon Pharmaceuticals For: May 12 | SEC filing · Form 8-K | -6.75% | -9.78% | |
| Form ARS Xenon Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | +0.00% | -1.13% | |
| Form DEF 14A Xenon Pharmaceuticals For: Apr 24 | SEC filing · Form DEF | +0.00% | -1.13% | |
| Form DEFA14A Xenon Pharmaceuticals | SEC filing · Form DEFA14A | +0.00% | -1.13% | |
| Form 8-K Xenon Pharmaceuticals For: Mar 14 | SEC filing · Form 8-K | -1.10% | -0.34% | |
| Form 8-K Xenon Pharmaceuticals For: Mar 03 | SEC filing · Form 8-K | +0.00% | +0.76% | |
| Form 10-K Xenon Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -9.54% | +0.05% | |
| Form 8-K Xenon Pharmaceuticals For: Feb 24 | SEC filing · Form 8-K | -9.54% | +0.05% | |
| Form S-8 Xenon Pharmaceuticals | SEC filing · Form S-8 | -9.54% | +0.05% | |
| Form 8-K Xenon Pharmaceuticals For: Jan 17 | SEC filing · Form 8-K | -0.10% | -3.27% | |
| Form 10-Q Xenon Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +1.21% | -2.58% | |
| Form 8-K Xenon Pharmaceuticals For: Nov 12 | SEC filing · Form 8-K | +1.21% | -2.58% | |
| Form S-3ASR Xenon Pharmaceuticals | SEC filing · Form S-3ASR | -2.30% | -1.30% | |
| Form 10-Q Xenon Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +5.63% | +7.53% | |
| Form 8-K Xenon Pharmaceuticals For: Aug 08 | SEC filing · Form 8-K | +5.63% | +7.53% | |
| Form 8-K Xenon Pharmaceuticals For: Jun 04 | SEC filing · Form 8-K | -0.42% | -1.10% | |
| Form S-8 Xenon Pharmaceuticals | SEC filing · Form S-8 | -0.42% | -1.10% | |
| Form 10-Q Xenon Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -2.75% | -0.54% | |
| Form 8-K Xenon Pharmaceuticals For: May 09 | SEC filing · Form 8-K | -2.75% | -0.54% | |
| Form ARS Xenon Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | -0.83% | +4.37% | |
| Form DEF 14A Xenon Pharmaceuticals For: Apr 26 | SEC filing · Form DEF | -0.83% | +4.37% | |
| Form 8-K Xenon Pharmaceuticals For: Apr 15 | SEC filing · Form 8-K | -0.48% | +0.23% | |
| Form 8-K Xenon Pharmaceuticals For: Mar 08 | SEC filing · Form 8-K | +0.00% | -2.91% | |
| Form 10-K Xenon Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -0.09% | -5.75% | |
| Form 8-K Xenon Pharmaceuticals For: Feb 29 | SEC filing · Form 8-K | -0.09% | -5.75% | |
| Form 8-K Xenon Pharmaceuticals For: Nov 29 | SEC filing · Form 8-K | +1.69% | +2.74% | |
| Form 8-K Xenon Pharmaceuticals For: Nov 27 | SEC filing · Form 8-K | +4.62% | +17.66% | |
| Form 8-K Xenon Pharmaceuticals For: Nov 09 | SEC filing · Form 8-K | -0.47% | -2.77% | |
| Form 10-Q Xenon Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -2.12% | -10.23% | |
| Form 8-K Xenon Pharmaceuticals For: Nov 08 | SEC filing · Form 8-K | -2.12% | -10.23% |
Keep exploring
More XENE: earnings → · analyst actions → · XENE overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AtriCure, Inc. (ATRC) | 276 | +0.04% | 51% |
| Coherus Oncology, Inc. (CHRS) | 276 | +0.21% | 51% |
| Aclaris Therapeutics, Inc. (ACRS) | 275 | 0.00% | 48% |
| Anika Therapeutics Inc. (ANIK) | 275 | +0.07% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.